The House passed a $1.15 trillion defense spending bill in July 2026, marking historic spending levels. The bill funds missile defense systems, shipbuilding, next-generation air platforms, and sustainment contracts across the defense industrial base.
House Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue
Record defense spending bill funds missile defense, shipbuilding, and next-gen air platforms—direct wins for prime contractors.

| Ticker | Company | 1-year change |
|---|---|---|
| LMT | Lockheed Martin | +3.3% |
| GD | General Dynamics | +9.0% |
| NOC | Northrop Grumman | −16.6% |
| LHX | L3Harris | −0.0% |
Record defense spending means record revenue for Lockheed, Raytheon, and General Dynamics—the Big Three lock in years of growth.
Direct winners are the "Big Three" defense primes: Lockheed Martin LMT, Raytheon Technologies (RTX), and General Dynamics GD. Lockheed gains from F-35 production and sustainment, missile defense (THAAD, Patriot), and space systems. Raytheon benefits from missile production (AIM-120, Tomahawk), radar systems, and integrated defense systems. General Dynamics wins on submarine construction (Columbia-class), combat vehicles, and IT services. Smaller primes like Northrop Grumman NOC and L3Harris LHX also benefit from increased spending on space, electronic warfare, and communications. Suppliers of specialized components, electronics, and materials—such as those in the portfolios of Anixter (AYX) and Tech Data (TECD)—see increased demand.
No direct losers, though international defense contractors face reduced U.S. market share. The spending surge is additive to the defense budget and supports domestic production.
Watch for defense contractor earnings calls in Q3 and Q4 2026 for guidance updates tied to the bill. Track contract awards from the Pentagon for specific program wins. Monitor supply chain announcements for capacity expansions.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.